These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30482161)

  • 1. Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients.
    Chang YC; Hsu BG; Liou HH; Lee CJ; Wang JH
    BMC Cardiovasc Disord; 2018 Nov; 18(1):214. PubMed ID: 30482161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between sclerostin and Dickkopf-1 with aortic arterial stiffness in patients with type 2 diabetes: A prospective, cross-sectional study.
    Yang HY; Wu DA; Chen MC; Hsu BG
    Diab Vasc Dis Res; 2019 May; 16(3):281-288. PubMed ID: 30547685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study.
    Hsu BG; Liou HH; Lee CJ; Chen YC; Ho GJ; Lee MC
    Medicine (Baltimore); 2016 Apr; 95(15):e3300. PubMed ID: 27082570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients.
    Wu CF; Hou JS; Wang CH; Lin YL; Lai YH; Kuo CH; Liou HH; Tsai JP; Hsu BG
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32075016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects.
    Stavrinou E; Sarafidis PA; Koumaras C; Loutradis C; Giamalis P; Tziomalos K; Karagiannis A; Papagianni A
    Kidney Blood Press Res; 2019; 44(4):679-689. PubMed ID: 31382263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum leptin is a predictor for central arterial stiffness in hypertensive patients.
    Tsai JP; Hsu BG; Lee CJ; Hsieh YH; Chen YC; Wang JH
    Nephrology (Carlton); 2017 Oct; 22(10):783-789. PubMed ID: 27450396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.
    Hou JS; Lin YL; Wang CH; Lai YH; Kuo CH; Subeq YM; Hsu BG
    BMC Nephrol; 2019 May; 20(1):184. PubMed ID: 31122190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.
    Hampson G; Edwards S; Conroy S; Blake GM; Fogelman I; Frost ML
    Bone; 2013 Sep; 56(1):42-7. PubMed ID: 23702386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sclerostin is a possible candidate marker of arterial stiffness: Results from a cohort study in Catania.
    Gaudio A; Fiore V; Rapisarda R; Sidoti MH; Xourafa A; Catalano A; Tringali G; Zanoli L; Signorelli SS; Fiore CE
    Mol Med Rep; 2017 May; 15(5):3420-3424. PubMed ID: 28339088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3-5.
    Lu JW; Chi PJ; Lin YL; Wang CH; Hsu BG
    Adipocyte; 2020 Dec; 9(1):206-211. PubMed ID: 32403968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with serum soluble inhibitors of Wnt-β-catenin signaling (sclerostin and dickkopf-1) in patients undergoing peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Ooboshi H; Kitazono T
    Nephrology (Carlton); 2015 Sep; 20(9):639-45. PubMed ID: 25974190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness.
    Thambiah S; Roplekar R; Manghat P; Fogelman I; Fraser WD; Goldsmith D; Hampson G
    Calcif Tissue Int; 2012 Jun; 90(6):473-80. PubMed ID: 22527202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum leptin levels with central arterial stiffness in coronary artery disease patients.
    Tsai JP; Wang JH; Chen ML; Yang CF; Chen YC; Hsu BG
    BMC Cardiovasc Disord; 2016 May; 16():80. PubMed ID: 27151106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Cohort Study of the Association between Serum Osteopontin Levels and Aortic Stiffness in Hypertensive Patients.
    Chang YC; Tsai JP; Wang JH; Hsu BG
    Int J Environ Res Public Health; 2022 Jan; 19(1):. PubMed ID: 35010737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum Mimecan Is Associated With Arterial Stiffness in Hypertensive Patients.
    Gu X; Zhao L; Zhu J; Gu H; Li H; Wang L; Xu W; Chen J
    J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26206738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus.
    Gaudio A; Privitera F; Pulvirenti I; Canzonieri E; Rapisarda R; Fiore CE
    Diab Vasc Dis Res; 2014 Jan; 11(1):48-52. PubMed ID: 24227537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum extracellular secreted antagonists of the canonical Wnt/β-catenin signaling pathway in patients with Cushing's syndrome.
    Belaya ZE; Rozhinskaya LY; Melnichenko GA; Solodovnikov AG; Dragunova NV; Iljin AV; Dzeranova LK; Dedov II
    Osteoporos Int; 2013 Aug; 24(8):2191-9. PubMed ID: 23358608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sclerostin level might be a potential biomarker for arterial stiffness in prevalent hemodialysis patients.
    Jin S; Zhu M; Yan J; Fang Y; Lu R; Zhang W; Zhang Q; Lu J; Qi C; Shao X; Zhang H; Jiang R; Ni Z
    Biomark Med; 2016 Jul; 10(7):689-99. PubMed ID: 27347702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension.
    Ma WH; Wang XL; Du YM; Wang YB; Zhang Y; Wei DE; Guo LL; Bu PL
    BMC Cardiovasc Disord; 2012 May; 12():35. PubMed ID: 22642467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients.
    Hou JS; Wang CH; Lai YH; Kuo CH; Lin YL; Hsu BG; Tsai JP
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.